The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.
More Latest News
June 12, 2020
Click here to view a full list of bill summaries from the 2020 Florida Legislative Session that may impact your profession. Continue reading
May 28, 2020
State Surgeon General Dr. Scott A. Rivkees issued Emergency Order DOH No. 20-008 extending the licensure renewal expiration with renewal deadlines between May 31, 2020 and July 31, 2020. Continue reading